A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease
Condition(s):Graft vs Host DiseaseLast Updated:March 6, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Graft vs Host DiseaseLast Updated:March 6, 2018Unknown status
Condition(s):Graft vs Host DiseaseLast Updated:November 27, 2018Completed
Condition(s):Chronic Graft-versus-host DiseaseLast Updated:January 18, 2016Unknown status
Condition(s):Hematologic MalignanciesLast Updated:August 31, 2016Withdrawn
Condition(s):Graft vs Host DiseaseLast Updated:March 22, 2017Completed
Condition(s):Graft Vs Host Disease; Graft-versus-host-disease; Acute-graft-versus-host Disease; Prevention of aGVHDLast Updated:April 25, 2023Completed
Condition(s):Graft-versus-host Disease (GVHD)Last Updated:July 18, 2023Completed
Condition(s):Intestinal GVHD; Neutropenic EnterocolitisLast Updated:October 3, 2012Unknown status
Condition(s):Graft-Versus-Host DiseaseLast Updated:February 26, 2016Completed
Condition(s):Graft vs Host DiseaseLast Updated:November 11, 2014Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.